Cargando…

Adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in Italy

BACKGROUND: This study aimed to analyze all the patients who contacted the hospital’s pediatric poison control center (PPCC) for exposure to ibuprofen and acetaminophen, in order to assess the incidence of any adverse reactions. METHODS: We retrospectively reported the clinical data of children who...

Descripción completa

Detalles Bibliográficos
Autores principales: Marano, Marco, Roversi, Marco, Severini, Flavia, Memoli, Claudia, Musolino, Antonio, Pisani, Mara, Cecchetti, Corrado, Villani, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925930/
https://www.ncbi.nlm.nih.gov/pubmed/36788576
http://dx.doi.org/10.1186/s13052-023-01427-6
_version_ 1784888163514187776
author Marano, Marco
Roversi, Marco
Severini, Flavia
Memoli, Claudia
Musolino, Antonio
Pisani, Mara
Cecchetti, Corrado
Villani, Alberto
author_facet Marano, Marco
Roversi, Marco
Severini, Flavia
Memoli, Claudia
Musolino, Antonio
Pisani, Mara
Cecchetti, Corrado
Villani, Alberto
author_sort Marano, Marco
collection PubMed
description BACKGROUND: This study aimed to analyze all the patients who contacted the hospital’s pediatric poison control center (PPCC) for exposure to ibuprofen and acetaminophen, in order to assess the incidence of any adverse reactions. METHODS: We retrospectively reported the clinical data of children who accessed the PPCC of the Bambino Gesù Children’s Hospital, IRCCS, Rome, from January 1, 2018 to September 30, 2022 due to wrong, accidental or intentional intake of inappropriate doses of acetaminophen and/or ibuprofen. In addition, we compared patients according to the intake of one of the two drugs and reported the trimestral distribution of cases during the study period. RESULTS: A total of 351 patients accessed the PPCC during the study period. The median age was 3.0 years. Most patients were females (57.8%). The most common reason for inappropriate oral intake of paracetamol or ibuprofen was a wrong use or an accidental intake (78.6%), with a fifth of patients taking the drug with suicidal intent (21.1%). According to the PPCC evaluation, most patients were not intoxicated (70.4%). Hospitalization was required for 30.5% of patients. Adverse reactions were reported in 10.5% of cases, with a similar incidence in patients who took paracetamol or ibuprofen. Nausea and vomiting were the most commonly reported adverse reactions. A higher frequency of moderate intoxication was found in patients who took paracetamol compared to ibuprofen (p = 0.001). The likelihood of intoxication was also higher in the paracetamol cohort. A spike of cases was registered at the end of 2021. CONCLUSIONS: We analyze exposures to the two most commonly used pediatric molecules, paracetamol and ibuprofen, to assess the frequency of adverse reactions. We demonstrated that these relatively “safe” drugs may be associated with intoxications and adverse reactions when inappropriately administered.
format Online
Article
Text
id pubmed-9925930
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99259302023-02-14 Adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in Italy Marano, Marco Roversi, Marco Severini, Flavia Memoli, Claudia Musolino, Antonio Pisani, Mara Cecchetti, Corrado Villani, Alberto Ital J Pediatr Research BACKGROUND: This study aimed to analyze all the patients who contacted the hospital’s pediatric poison control center (PPCC) for exposure to ibuprofen and acetaminophen, in order to assess the incidence of any adverse reactions. METHODS: We retrospectively reported the clinical data of children who accessed the PPCC of the Bambino Gesù Children’s Hospital, IRCCS, Rome, from January 1, 2018 to September 30, 2022 due to wrong, accidental or intentional intake of inappropriate doses of acetaminophen and/or ibuprofen. In addition, we compared patients according to the intake of one of the two drugs and reported the trimestral distribution of cases during the study period. RESULTS: A total of 351 patients accessed the PPCC during the study period. The median age was 3.0 years. Most patients were females (57.8%). The most common reason for inappropriate oral intake of paracetamol or ibuprofen was a wrong use or an accidental intake (78.6%), with a fifth of patients taking the drug with suicidal intent (21.1%). According to the PPCC evaluation, most patients were not intoxicated (70.4%). Hospitalization was required for 30.5% of patients. Adverse reactions were reported in 10.5% of cases, with a similar incidence in patients who took paracetamol or ibuprofen. Nausea and vomiting were the most commonly reported adverse reactions. A higher frequency of moderate intoxication was found in patients who took paracetamol compared to ibuprofen (p = 0.001). The likelihood of intoxication was also higher in the paracetamol cohort. A spike of cases was registered at the end of 2021. CONCLUSIONS: We analyze exposures to the two most commonly used pediatric molecules, paracetamol and ibuprofen, to assess the frequency of adverse reactions. We demonstrated that these relatively “safe” drugs may be associated with intoxications and adverse reactions when inappropriately administered. BioMed Central 2023-02-14 /pmc/articles/PMC9925930/ /pubmed/36788576 http://dx.doi.org/10.1186/s13052-023-01427-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Marano, Marco
Roversi, Marco
Severini, Flavia
Memoli, Claudia
Musolino, Antonio
Pisani, Mara
Cecchetti, Corrado
Villani, Alberto
Adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in Italy
title Adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in Italy
title_full Adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in Italy
title_fullStr Adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in Italy
title_full_unstemmed Adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in Italy
title_short Adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in Italy
title_sort adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in italy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925930/
https://www.ncbi.nlm.nih.gov/pubmed/36788576
http://dx.doi.org/10.1186/s13052-023-01427-6
work_keys_str_mv AT maranomarco adversedrugsreactionstoparacetamolandibuprofeninchildrena5yearreportfromapediatricpoisoncontrolcenterinitaly
AT roversimarco adversedrugsreactionstoparacetamolandibuprofeninchildrena5yearreportfromapediatricpoisoncontrolcenterinitaly
AT severiniflavia adversedrugsreactionstoparacetamolandibuprofeninchildrena5yearreportfromapediatricpoisoncontrolcenterinitaly
AT memoliclaudia adversedrugsreactionstoparacetamolandibuprofeninchildrena5yearreportfromapediatricpoisoncontrolcenterinitaly
AT musolinoantonio adversedrugsreactionstoparacetamolandibuprofeninchildrena5yearreportfromapediatricpoisoncontrolcenterinitaly
AT pisanimara adversedrugsreactionstoparacetamolandibuprofeninchildrena5yearreportfromapediatricpoisoncontrolcenterinitaly
AT cecchetticorrado adversedrugsreactionstoparacetamolandibuprofeninchildrena5yearreportfromapediatricpoisoncontrolcenterinitaly
AT villanialberto adversedrugsreactionstoparacetamolandibuprofeninchildrena5yearreportfromapediatricpoisoncontrolcenterinitaly